Circulation

Vol. 152, Issue 25 Issue 25 2025
11
Articles

Articles in this Issue

Nuclear eNOS Interacts With and <i>S</i> -Nitrosates ADAR1 to Modulate Type I Interferon Signaling and Endothelial Function

Xiaozhu Zhou, Carsten Kuenne, Stefan Günther et al. Dec 23, 2025 pp. 1781-1799 10.1161/circulationaha.125.074889

BACKGROUND: Nitric oxide (NO), generated by the endothelial NO synthase (eNOS), regulates vascular tone and endothelial homeostasis to counteract vascular inflammation. Most eNOS i...

Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure: The ANDES Randomized Clinical Trial

Josep Rodés-Cabau, Luis Nombela-Franco, Ignacio Cruz-González et al. Dec 23, 2025 pp. 1759-1768 10.1161/circulationaha.125.077469

BACKGROUND: The optimal antithrombotic treatment after transcatheter left atrial appendage closure (LAAC) remains to be determined. The objective of this trial was to compare antic...

Challenges of Clinical Trials in Cardio-Oncology: Navigating Surrogate Outcomes and Identifying Patients at Risk of Late Cardiovascular Complications

Peter A. Henriksen Dec 23, 2025 pp. 1756-1758 10.1161/circulationaha.125.077629

Coronary Artery Revascularization in the Older Adult Population: A Scientific Statement From the American Heart Association

Abdulla A. Damluji, Michael G. Nanna, Peter Mason et al. Dec 23, 2025 10.1161/cir.0000000000001387

The United States is facing a demographic shift as the population of older adults grows rapidly, with the proportion of Americans ≥65 years of age projected to double by 2060. This aging trend will ha...

Sacubitril-Valsartan for the Prevention of Anthracycline Cardiotoxicity in Patients With Elevated Cardiac Troponin I Concentration During Chemotherapy: A Double-Blind Randomized Placebo-Controlled Clinical Trial: The SARAH Trial

Luka David Lechinewski, Amanda de Nadai Costa, Andressa de Oliveira Coiradas et al. Dec 23, 2025 pp. 1742-1755 10.1161/circulationaha.125.073322

BACKGROUND: The clinical effects of sacubitril-valsartan, an angiotensin receptor-neprilysin inhibitor, on anthracycline-induced cardiotoxicity remain unknown. Experimental evidenc...

Late-Breaking Science Abstracts and Featured Science Abstracts From the American Heart Association's Scientific Sessions 2025 and Late-Breaking Abstracts in Resuscitation Science From the Resuscitation Science Symposium 2025

Dec 23, 2025 10.1161/cir.0000000000001403

Letter by Hang et al Regarding Article, “An NRF2/β3-Adrenoreceptor Axis Drives a Sustained Antioxidant and Metabolic Rewiring Through the Pentose-Phosphate Pathway to Alleviate Cardiac Stress”

Peng-zhou Hang, Ting-ting Tan, Jing Zhao Dec 23, 2025 10.1161/circulationaha.125.076009

A Common Ancestry-Specific Sodium Channel Variant Increases Susceptibility to Drug-Induced QTc Prolongation: Evidence From a Large Biobank

Russell Stewart, Brandon D. Lowery, Eric Farber-Eger et al. Dec 23, 2025 pp. 1806-1808 10.1161/circulationaha.125.074358

Response by Balligand and Michel to Letter Regarding Article, “An NRF2/β3-Adrenoreceptor Axis Drives a Sustained Antioxidant and Metabolic Rewiring Through the Pentose-Phosphate Pathway to Alleviate Cardiac Stress”

Jean-Luc Balligand, Lauriane Y.M. Michel Dec 23, 2025 10.1161/circulationaha.125.077505

Linearity in Regression Models: Meaning, Implications, and How to Handle it

Andrea Bellavia, Sabina A. Murphy Dec 23, 2025 pp. 1739-1741 10.1161/circulationaha.125.073647

Quantitative Identification of High-Risk Tricuspid Regurgitation by Cardiac Magnetic Resonance

Davide Margonato, Maurice Enriquez-Sarano, Takahiro Nishihara et al. Dec 23, 2025 pp. 1769-1780 10.1161/circulationaha.125.074862

BACKGROUND: The role of cardiac magnetic resonance (CMR) quantification of tricuspid regurgitation (TR) to identify high-risk patients with TR remains poorly defined. The aim of th...

All Issues

Journal Info

Publisher Lippincott Williams & Wilkins
ISSN 0009-7322
E-ISSN 1524-4539
Subject Health Sciences
Language English
View Full Journal Page